Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases

Bruce A. Bunnell, Weiwen Deng, Christine M. Robinson, Paul R. Waldron, Trinity J. Bivalacqua, Syed R. Baber, Albert L. Hyman, Philip J. Kadowitz

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Stem cells isolated from various sources have been shown to vary in their differentiation capacity or pluripotentiality. Two groups of stem cells, embryonic and adult stem cells, may be capable of differentiating into any desired tissue or cell type, which offers hope for the development of therapeutic applications for a large number of disorders. However, major limitations with the use of embryonic stem cells for human disease have led researchers to focus on adult stem cells as therapeutic agents. Investigators have begun to examine postnatal sources of pluripotent stem cells, such as bone marrow stroma or adipose tissue, as sources of mesenchymal stem cells. The following review focuses on recent research on the use of stem cells for the treatment of cardiovascular and pulmonary diseases and the future application of mesenchymal stem cells for the treatment of a variety of cardiovascular disorders.

Original languageEnglish
Pages (from-to)529-539
Number of pages11
JournalCanadian Journal of Physiology and Pharmacology
Issue number7
StatePublished - Jul 2005


  • CGRP
  • Gene therapy
  • Stem cells
  • eNOS


Dive into the research topics of 'Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases'. Together they form a unique fingerprint.

Cite this